Hepatitis E Virus Infection in Iranian Kidney-Transplant Patients

Hepatitis Monthly

Volumn 11, Issue 11, 2011, Pages 927-928

  Kamar, Nassim ^a  

^a CHU RANGUEIL   (France)

Author keywords

Hepatitis E; Kidney Transplantation; Patients

Indexed keywords

EID: 85141859176     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.791     Document Type: Letter

References (8)

1. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8(11):698-709.
2. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811-7.
3. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzi-bet J, et al. Chronic Hepatitis After Hepatitis E Virus Infection in a Patient With Non-Hodgkin Lymphoma Taking Rituximab. Ann Intern Med. 2009;150(6):430-1.
4. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent car-riage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361(10):1025-27.
5. Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavays-siere L, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation. 2010;89(3):353-60.
6. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140(5):1481-9.
7. Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Es-posito L, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology. 2010;139(5):1612-8.
8. Khameneh ZR, Sepehrvand N, Masudi S. Seroprevalence of Hepatitis E among Iranian renal transplant recipients. Hepat Mon. 2011;11(8):646-51. 9. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two com-mercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82(5):799-805.